Aprea Company
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Funding Status:
IPO
Headquarters:
Stockholm, Stockholms Lan, Sweden
Founded Date:
2003
Employee Number:
11-50
Last Funding Type:
Venture - Series Unknown
Total Funding:
$5.2M
Estimated Revenue:
$1M to $10M
Industry:
PharmTech
Investors Number:
2
Technology:
Data-driven Technologies
Investor Type:
For Profit